Mar 21, 2014 | Coding, Billing, and Collections, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
Cloud-based genetic research networks that facilitate collaboration by stakeholders worldwide may solve the most difficult disease challenges, including a cure for cancer Coming soon to a clinical laboratory near you: cloud-based “big data” genome analysis! A new industry is emerging dedicated to accepting, storing, and analyzing vast quantities of data generated by next-generation gene sequencing and whole human-genome sequencing. There are already examples of academic departments of...
Jul 5, 2013 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Operations, Laboratory Pathology, Uncategorized
Separate research projects at University of Washington and in the United Kingdom are producing handheld diagnostic devices to accurately detect Malaria Two new handheld, point-of-care test (POC) devices for malaria could save millions of lives in third-world countries. At the same time, these POC devices may lead to inexpensive alternatives for diagnosing common diseases in developed nations as well. Clinical laboratory test developers see a big opportunity in developing assays to detect...
Sep 14, 2011 | Laboratory Hiring & Human Resources, Laboratory News, Laboratory Pathology
In Silicon Valley, biotech and molecular companies “raid” hospital laboratories to hire away MTs and CLSs Competition for already hard-to-find medical technologists (MT) and clinical laboratory scientists (CLS) is heating up as biomedical and molecular development companies vie with hospitals and medical laboratories for these highly-prized workers. Growth in demand for MTs and CLSs by biotech companies means that clinical laboratories will face stiff competition when recruiting and hiring for...
Jun 4, 2010 | Laboratory News, Laboratory Pathology
Milestone achievement may lead to more sophisticated clinical laboratory tests Now science can create synthetic life forms and J. Craig Venter, Ph.D., is the first to do it. The landmark feat, which involved building the genome of a bacterium from scratch and incorporating it into a cell, “paves the way for designer organisms that are built rather than evolved,” noted the author of an article in guardian.co.uk. J. Craig Venter, Ph.D., best known to pathologists and clinical laboratory...
May 19, 2010 | Laboratory News, Laboratory Pathology
Use of synthetic antibodies and a finger prick sample of blood could give clinical laboratories new tool to screen for breast cancer A simple clinical pathology laboratory blood test for early detection of breast cancer may be just around the corner. At the University of Arkansas (UA), researchers are building a library of synthetic antibodies called affitoids that can be used to detect breast cancer in its earliest stage. Researchers believe they are closing in on the creation of an assay...
